Literature DB >> 18443312

T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation.

A McNeill1, D Birchall, S J Hayflick, A Gregory, J F Schenk, E A Zimmerman, H Shang, H Miyajima, P F Chinnery.   

Abstract

BACKGROUND: Neurodegeneration with brain iron accumulation (NBIA) defines a group of genetic disorders characterized by brain iron deposition and associated with neuronal death. The known causes of NBIA include pantothenate kinase-associated neurodegeneration (PKAN), neuroferritinopathy, infantile neuroaxonal dystrophy (INAD), and aceruloplasminemia.
OBJECTIVE: To define the radiologic features of each NBIA subtype.
METHODS: Brain MRIs from patients with molecularly confirmed PKAN (26 cases), neuroferritinopathy (21 cases), INAD (four cases), and aceruloplasminemia (10 cases) were analyzed blindly to delineate patterns of iron deposition and neurodegeneration.
RESULTS: In most cases of PKAN, abnormalities were restricted to globus pallidus and substantia nigra, with 100% having an eye of the tiger sign. In a minority of PKAN cases there was hypointensity of the dentate nuclei (1/5 on T2* sequences, 2/26 on fast spin echo [FSE]). In INAD, globus pallidus and substantia nigra were involved on T2* and FSE scans, with dentate involvement only seen on T2*. By contrast, neuroferritinopathy had consistent involvement of the dentate nuclei, globus pallidus, and putamen, with confluent areas of hyperintensity due to probable cavitation, involving the pallida and putamen in 52%, and a subset having lesions in caudate nuclei and thalami. More uniform involvement of all basal ganglia and the thalami was typical in aceruloplasminemia, but without cavitation.
CONCLUSIONS: In the majority of cases, different subtypes of neurodegeneration associated with brain iron accumulation can be reliably distinguished with T2* and T2 fast spin echo brain MRI, leading to accurate clinical and subsequent molecular diagnosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18443312      PMCID: PMC2706154          DOI: 10.1212/01.wnl.0000310985.40011.d6

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  24 in total

1.  A case of aceruloplasminaemia: abnormal serum ceruloplasmin protein without ferroxidase activity.

Authors:  Y Takeuchi; M Yoshikawa; T Tsujino; S Kohno; N Tsukamoto; A Shiroi; E Kikuchi; H Fukui; H Miyajima
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

2.  T(2) relaxation rate of basal ganglia and cortex in patients with beta-thalassaemia major.

Authors:  Z Metafratzi; M I Argyropoulou; D N Kiortsis; C Tsampoulas; N Chaliassos; S C Efremidis
Journal:  Br J Radiol       Date:  2001-05       Impact factor: 3.039

Review 3.  Potential sources of increased iron in the substantia nigra of parkinsonian patients.

Authors:  M Gerlach; K L Double; M B H Youdim; P Riederer
Journal:  J Neural Transm Suppl       Date:  2006

4.  Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease.

Authors:  A R Curtis; C Fey; C M Morris; L A Bindoff; P G Ince; P F Chinnery; A Coulthard; M J Jackson; A P Jackson; D P McHale; D Hay; W A Barker; A F Markham; D Bates; A Curtis; J Burn
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

5.  A novel mutation of the ceruloplasmin gene in a patient with heteroallelic ceruloplasmin gene mutation (HypoCPGM).

Authors:  M Daimon; S Susa; T Ohizumi; S Moriai; T Kawanami; A Hirata; H Yamaguchi; H Ohnuma; M Igarashi; T Kato
Journal:  Tohoku J Exp Med       Date:  2000-07       Impact factor: 1.848

6.  Wilson's disease tremor is associated with magnetic resonance imaging lesions in basal ganglia structures.

Authors:  Martin Südmeyer; Andreas Saleh; Lars Wojtecki; Mathias Cohnen; Joachim Gross; Markus Ploner; Harald Hefter; Lars Timmermann; Alfons Schnitzler
Journal:  Mov Disord       Date:  2006-12       Impact factor: 10.338

7.  Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from alzheimer's disease patients.

Authors:  Michael J House; Timothy G St Pierre; Kris V Kowdley; Thomas Montine; James Connor; John Beard; Jose Berger; Narendra Siddaiah; Eric Shankland; Lee-Way Jin
Journal:  Magn Reson Med       Date:  2007-01       Impact factor: 4.668

8.  Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights.

Authors:  Olivier Loréal; Bruno Turlin; Christelle Pigeon; Annick Moisan; Martine Ropert; Patrick Morice; Yves Gandon; Anne-Marie Jouanolle; Marc Vérin; Robert C Hider; Kunihiro Yoshida; Pierre Brissot
Journal:  J Hepatol       Date:  2002-06       Impact factor: 25.083

Review 9.  Neurodegeneration with brain iron accumulation: from genes to pathogenesis.

Authors:  Susan J Hayflick
Journal:  Semin Pediatr Neurol       Date:  2006-09       Impact factor: 1.636

10.  Anemia and iron overload due to compound heterozygosity for novel ceruloplasmin mutations.

Authors:  Sandra Bosio; Marco De Gobbi; Antonella Roetto; Gabriella Zecchina; Eugenio Leonardo; Mario Rizzetto; Claudio Lucetti; Lucia Petrozzi; Ubaldo Bonuccelli; Clara Camaschella
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

View more
  90 in total

1.  'Eye-of-the-tiger' sign and classic pantothenate kinase associated neurodegeneration.

Authors:  Mahesh Kamate; Rajendra Mali; Vinayak Tonne; Shivanand Bubanale
Journal:  Indian J Pediatr       Date:  2010-09-30       Impact factor: 1.967

2.  Identification of Novel Compound Mutations in PLA2G6-Associated Neurodegeneration Patient with Characteristic MRI Imaging.

Authors:  Sen Guo; Liu Yang; Huijie Liu; Wei Chen; Jinchen Li; Ping Yu; Zhong Sheng Sun; Xiang Chen; Jie Du; Tao Cai
Journal:  Mol Neurobiol       Date:  2016-07-09       Impact factor: 5.590

Review 3.  Genetics of neurodegeneration with brain iron accumulation.

Authors:  Allison Gregory; Susan J Hayflick
Journal:  Curr Neurol Neurosci Rep       Date:  2011-06       Impact factor: 5.081

Review 4.  Acquired hepatocerebral degeneration.

Authors:  Joseph Ferrara; Joseph Jankovic
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

Review 5.  Pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN): review of two major neurodegeneration with brain iron accumulation (NBIA) phenotypes.

Authors:  Manju A Kurian; Susan J Hayflick
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

6.  A Novel Deletion Mutation of Exon 2 of the C19orf12 Gene in an Omani Family with Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN).

Authors:  Nabil Al Macki; Ismail Al Rashdi
Journal:  Oman Med J       Date:  2017-01

7.  Nigropallidal iron accumulation in pantothenate kinase-associated neurodegeneration demonstrated by susceptibility-weighted imaging.

Authors:  Jae-Hyeok Lee; Dae-Seong Kim; Seung-Kug Baik; Sang-Ook Nam
Journal:  J Neurol       Date:  2009-12-05       Impact factor: 4.849

8.  Cortical pencil lining in neuroferritinopathy: a diagnostic clue.

Authors:  Amit Batla; Matthew E Adams; Roberto Erro; Christos Ganos; Bettina Balint; Niccolo E Mencacci; Kailash P Bhatia
Journal:  Neurology       Date:  2015-04-01       Impact factor: 9.910

Review 9.  Clinical and genetic delineation of neurodegeneration with brain iron accumulation.

Authors:  A Gregory; B J Polster; S J Hayflick
Journal:  J Med Genet       Date:  2008-11-03       Impact factor: 6.318

10.  Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation.

Authors:  David Devos; P Jissendi Tchofo; Isabelle Vuillaume; Alain Destée; Stephanie Batey; John Burn; Patrick F Chinnery
Journal:  Brain       Date:  2008-10-14       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.